Ragab Eman M, Khamis Abeer A, Gamal Doaa M El, Mohamed Tarek M
Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt.
Genes Nutr. 2024 May 27;19(1):10. doi: 10.1186/s12263-024-00740-x.
Mitochondrial respiration complexes play a crucial function. As a result, dysfunction or change is intimately associated with many different diseases, among them cancer. The epigenetic, evolutionary, and metabolic effects of mitochondrial complex IΙ are the primary concerns of our review. Provides novel insight into the vital role of naringenin (NAR) as an intriguing flavonoid phytochemical in cancer treatment. NAR is a significant phytochemical that is a member of the flavanone group of polyphenols and is mostly present in citrus fruits, such as grapefruits, as well as other fruits and vegetables, like tomatoes and cherries, as well as foods produced from medicinal herbs. The evidence that is now available indicates that NAR, an herbal remedy, has significant pharmacological qualities and anti-cancer effects. Through a variety of mechanisms, including the induction of apoptosis, cell cycle arrest, restriction of angiogenesis, and modulation of several signaling pathways, NAR prevents the growth of cancer. However, the hydrophobic and crystalline structure of NAR is primarily responsible for its instability, limited oral bioavailability, and water solubility. Furthermore, there is no targeting and a high rate of breakdown in an acidic environment. These shortcomings are barriers to its efficient medical application. Improvement targeting NAR to mitochondrial complex ΙΙ by loading it on chitosan nanoparticles is a promising strategy.
线粒体呼吸复合体发挥着至关重要的作用。因此,功能障碍或变化与许多不同疾病密切相关,其中包括癌症。线粒体复合体II的表观遗传、进化和代谢效应是我们综述的主要关注点。本文提供了关于柚皮素(NAR)作为一种有趣的类黄酮植物化学物质在癌症治疗中重要作用的新见解。NAR是一种重要的植物化学物质,属于黄酮酮类多酚,主要存在于柑橘类水果如葡萄柚中,以及其他水果和蔬菜如西红柿和樱桃中,还有草药制成的食品中。现有证据表明,草药NAR具有显著的药理特性和抗癌作用。通过多种机制,包括诱导细胞凋亡、细胞周期阻滞、限制血管生成以及调节多种信号通路,NAR可抑制癌症生长。然而,NAR的疏水和晶体结构主要导致其不稳定、口服生物利用度有限以及水溶性差。此外,在酸性环境中无靶向性且分解率高。这些缺点阻碍了其有效的医学应用。通过将NAR负载在壳聚糖纳米颗粒上靶向线粒体复合体II是一种有前景的策略。